PRECISION NAVIGATION FOR COMPLEX VASCULAR DISEASE

Flux Robotics develops magnetic navigation systems to solve the most challenging bottleneck in vascular intervention: controlled true-lumen access in complex CTO.

Explore Our Clinical Focus

THE CTO BOTTLENECK

In complex lower-limb Chronic Total Occlusion (CTO), guidewire crossing remains the primary procedural uncertainty.

Failed crossing drives longer procedures, higher device usage, and increased complication risk.

High device spend per case
High learning curve
Limited true-lumen control

Proximal cap

CTO (Blockage)

Subintimal space

MEET THE TEAM

Christoff Heunis, CEO
PhD Surgical Robotics. Founder. Leads clinical strategy, indication focus, and investor alignment.

Wimold Peters, CTO
Leads product architecture, systems engineering, and the staged complexity roadmap from MVP to scalable platform.

Robert Beasley, CMO
U.S. vascular surgeon. Leads FDA strategy, clinical trial design, and First-in-Human execution.

Saskia ten Siethoff, QA/RA Lead
Leads regulatory strategy and quality systems implementation. Responsible for ISO 13485 execution and compliance across all development phases.

Michiel Richter, Lead Engineer
PhD Robotics and Control. Leads systems integration, navigation algorithms, and magnetic control optimization.

Hanna Heijs, Biomedical Engineer
Supports device validation, pre-clinical testing, and translational integration between engineering and clinical partners.

Advisors and Mentors

Doron Dinstein, Market Strategy
Leads go-to-market strategy, reimbursement positioning, and U.S. market access. Former Johnson & Johnson executive with extensive MedTech commercialization experience.

Albert-Jan de Croes, Financial Strategy
Supports capital strategy, funding structuring, and investor relations. Affiliated with UT Holding and early-stage venture financing.

CLINICAL PROGRESS

Pre-clinical in-vivo feasibility completed.
Preparing GLP validation and First-in-Human CTO study.
Targeted regulatory pathway toward US market entry.

Strategic & Industry Support

Robert Beasley

A board-certified vascular surgeon and interventional radiologist specializing in carotid artery stenting and vascular repair, Dr. Beasley brings strategic insight to clinical research, regulatory pathways, and early adoption strategies in advanced endovascular technologies.

Alan Lumsden

A renowned vascular and endovascular surgeon and Medical Director at Houston Methodist DeBakey Heart & Vascular Center, Dr. Lumsden provides clinical expertise in aortic and complex arterial disease management, strengthening clinical credibility and guiding global clinical engagement efforts.

Miguel Montero-Baker

Associate Professor and vascular surgeon with expertise in critical limb ischemia, limb salvage, and peripheral interventions, Dr. Montero-Baker supports Flux’s clinical validation strategy and expands engagement within high-impact European and U.S. specialist communities.

OUR SURGICAL TEAM

Lorenzo Patrone

An international vascular interventional radiologist and prolific contributor to endovascular literature, Dr. Patrone offers critical insight into technical procedure optimization, evidence generation strategies, and clinical trial design for complex revascularization workflows.

Anahita Dua

Associate Professor at Harvard Medical School and Director of Vascular Services at Massachusetts General Hospital, Dr. Dua brings leadership in clinical outcomes research, advanced limb salvage techniques, and device evaluation — key for building evidence of safety, effectiveness, and cost impact.

Medical Advisory Board

Michael Lichtenberg, Clinical Innovation

Director of Vascular Intervention at Beth Israel Deaconess and Section Head of Interventional Research, Dr. Secemsky offers world-class expertise in peripheral intervention, comparative outcomes research, real-world evidence, and clinical trial methodology — instrumental to Flux’s evidence-driven adoption strategy.

Bob Geelkerken, Clinical Translation

Professor, MST Netherlands. Guides translational integration and clinical implementation strategy.

Michel Reijnen, Vascular Imaging

Professor of Vascular Imaging, Rijnstate. Advises on imaging strategy and procedural precision.

Jean-Paul de Vries, Vascular Surgery

Chair of Vascular Surgery, UMCG. Advises on complex vascular procedures and clinical validation.

Michael Lichtenberg, Clinical Innovation

Head of Angiology, Vascular Centre Clinic Arnsberg. Supports CTO clinical positioning and adoption.

Scientific Advisory Board